Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the Underlying Mechanisms of Targeted Therapy Related Toxicities

NCT01758575 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT01758575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01758575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the Underlying Mechanisms of Targeted Therapy Related Toxicities
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Terminated
Start date
November 30, 2012
Completion date
April 30, 2017
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or metastatic solid malignancy